APLN and pancreatic neoplasm: Our data clearly establish that the co-expression of apelin and APJ by pancreatic tumor cells fosters tumor growth, whereas loss of the apelin receptor dramatically reduces the tumor burden in murine orthotopic xenograft experiments.